Renasant Corp (RNST) · Oct 27, 2026 · Acquisition
$142M acquisition — ~4% 2028 EPS accretion; <1.5% TBV dilution; two-year TBV earnback
Renasant’s acquisition of Commercial Bank expands its West Tennessee footprint with nearly $1B of deposits and projected 2028 EPS accretion, but creates upfront dilution.
Renasant is an acquisitive Southeast bank using whole-bank deals and de novo expansion to deepen its regional footprint; this transaction extends that playbook into West Tennessee and Memphis. The company already operates at roughly $27 billion of assets and has a history of acquisitions, so the strategic direction is familiar—but this specific target and its economics are new.
The deal adds a strategically useful deposit franchise, not just balance sheet size. Commercial brings nine Tennessee branches, approximately $983 million of deposits, $648 million of loans and $1.2 billion of wealth-management assets as of September 30, 2026. The key asset is the deposit base: the presentation describes 93% of deposits as core, 22% as noninterest-bearing and the bank as having no brokered deposits. (Exhibit 99.2, “Deposit Highlights”)
| Deal metric | Filing figure | Comparison / implication |
|---|---|---|
| Transaction value | ~$142 million | Based on RNST’s $40.29 10-day average price (Exhibit 99.1) |
| Stock issued | ~2.64 million shares | Fixed 0.8798 RNST shares per Commercial share (Merger Consideration) |
| Special cash dividend | ~$35.7 million | Paid by Commercial before closing (Exhibit 99.1) |
| 2028 EPS impact | ~4% accretion | Company projection (Exhibit 99.2, “Financial Impact”) |
| Tangible book value impact | <1.5% dilution | Estimated at closing (Exhibit 99.2, “Financial Impact”) |
| TBV earnback | 2 years | Crossover method (Exhibit 99.2, “Financial Impact”) |
| After-tax merger charges | $19.0 million | Assumed transaction cost (Exhibit 99.2, “Financial Impact”) |
The terms look disciplined relative to comparable bank deals, while the accretion case depends on execution. Renasant is paying 6.0% of core deposits versus a 8.7% median for comparable Southeast transactions, and the presentation shows a 7.7x transaction value-to-earnings multiple including fully phased-in cost savings versus 7.4x for those comparables. (Exhibit 99.2, “Transaction Summary”) The projected 4% 2028 EPS accretion is therefore meaningful, but it relies on realizing 25% of Commercial’s noninterest expense savings, with only 50% expected in 2027 and 100% thereafter. (Exhibit 99.2, “Financial Impact”)
The main complication is that Renasant is taking on integration and control risk during an already important operating transition. The filing flags Renasant’s unresolved material weakness in internal controls as a risk to the combined company. 〔0〕 That does not invalidate the deal, but it makes the promised cost savings and clean integration more consequential than the headline accretion suggests.
The transaction is agreed, but not yet secured. The boards approved it unanimously, the parties expect a first-quarter 2027 closing, and directors representing 50% of Commercial’s voting shares have signed voting agreements. 〔1〕 Regulatory approvals, Commercial shareholder approval and the S-4 registration process remain outstanding. 〔2〕
Bottom line: This advances Renasant’s regional expansion with a high-quality, low-cost deposit base and a reasonably priced, projected-accretive deal. It matters because the economics are attractive on paper, but the value now shifts to regulatory approval, integration and delivery of the cost savings rather than deal announcement alone.
Form S-4 filing and Commercial shareholder vote
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!